Table 2 Demographics of patients admitted to COVID virtual ward
Total (n = 238) | Early discharge (n = 138) | Admission avoidance (n = 100) | p-value | |
|---|---|---|---|---|
Age, mean (SD) | 62.5 (19.1) | 61.7 (19.8) | 63.7 (18.0) | 0.41 |
Age | 0.73 | |||
< 50 | 56 (23.5) | 36 (26.1) | 20 (20.0) | |
50–59 | 37 (15.5) | 20 (14.5) | 17 (17.0) | |
60–69 | 41 (17.2) | 22 (15.9) | 19 (19.0) | |
70–79 | 54 (22.7) | 33 (23.9) | 21 (21.0) | |
≥ 80 | 50 (21.0) | 27 (19.6) | 23 (23.0) | |
Male, n (%) | 101 (42.4) | 57 (41.3) | 44 (44.0) | 0.78 |
Race n(%) | 0.65 | |||
Chinese | 161 (67.6) | 94 (68.1) | 67 (67.0) | |
Malay | 40 (16.8) | 27 (19.6) | 13 (13.0) | |
Indian | 16 (6.7) | 7 (5.1) | 9 (9.0) | |
Others | 21 (8.8) | 10 (7.2) | 11 (11.0) | |
Not fully vaccinated, n(%) | 86 (36.6) | 61 (44.2) | 25 (25.0) | 0.004 |
Immunocompromised, n(%) | ||||
Total | 49 (20.5) | 31 (22.4) | 18 (18.0) | 0.04 |
Organ transplant | 12 (24.4) | 9 (29.0) | 3 (16.7) | |
Chemotherapy | 20 (40.8) | 11 (35.4) | 9 (50.0) | |
Haematological malignancy | 8 (16.3) | 8 (25.8) | 0 (0) | |
Non-cancer immunosuppression | 9 (18.3) | 3 (9.7) | 6 (33.3) | |
Pregnant, n(%) | ||||
Total | 16 (6.7) | 16 (11.6) | 0 | NA |
1st trimester | 1 (6.2) | 1 (6.2) | 0 | |
2nd trimester | 8 (50) | 8 (50) | 0 | |
3rd trimester | 7 (44) | 7 (44) | 0 | |
Comorbidities, n(%) | 0.61 | |||
0 | 99 (41.6) | 60 (43.5) | 39 (39.0) | |
1 | 75 (31.5) | 40 (29.0) | 35 (35.0) | |
≥ 2 | 64 (26.9) | 38 (27.5) | 26 (26.0) | |
ISARIC 4C Mortality Score | ||||
Median [IQR] | 6 [3, 8] | 6 [2, 8] | 6 [3, 8] | 0.77 |
0–3 (low risk), n(%) | 71 (29.8) | 45 (32.6) | 26 (26.0) | 0.224 |
4–8 (intermediate risk), n%() | 120 (50.4) | 63 (45.7) | 57 (57.0) | |
≥ 9 (high risk), n(%) | 47 (19.7) | 30 (21.7) | 17 (17.0) | |
Day of COVID illness at admission, median [IQR] | 4 [2, 7] | 6 [4, 7] | 3 [2, 6] | < 0.001 |
LOS in virtual ward, median [IQR] | 6 [3, 8] | 6 [3, 8] | 7 [4, 8] | 0.33 |